Most Popular Stories
- GSK, Takeda say nay to in-house diagnostics units
- Merck says Victrelis can interfere with HIV meds
- Novartis CEO calls external focus key to fast-changing pharma
- LEO Pharma slapped with sales-rep overtime suit
- EMC to found Russian cloud computing, 'Big Data' hub
- Psychologists petition against DSM-5 revisions
Webinars
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
Featured Jobs
-
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Manager, Business Development
Clinical Resource Network - Chicago, IL -
Sr. Manager, Market Research Job
Celgene Corporation - Summit, NJ, US -
Sr. Director, Alliance Management Job
Celgene Corporation - Summit, NJ, US -
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA
Events
- Connect, Collaborate, & Innovate: MassBio Annual Meeting
March 26-27 — Cambridge, MA - Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Just Released: New Trends in Preventive and Therapeutic Vaccine
- CALBIO2012: Driven By Patients - Marriott Marquis
March 8-9 — San Francisco, CA
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Commercial Insight: Top 20 Cancer Therapy Brands
- The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries
- The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics
- Social Media and Post-Marketing Drug Safety
- Displacement Chromatography Comes of Age - An indispencable tool for the purification of biomacromolecules
- Let travelers smell your rich media content
Biogen Idec CEO Jim Mullen
